The underlying pathology of atopic dermatitis (AD) includes impaired skin barrier function,
susceptibility to Staphylococcus aureus skin infection, immune dysregulation, and cutaneous …

Dysbiosis of the skin microbiota is increasingly implicated as a contributor to the pathogenesis
of atopic dermatitis (AD). We previously reported first-in-human safety and clinical activity …

Atopic dermatitis (AD) is a chronic inflammatory skin condition increasing in industrial
nations at a pace that suggests environmental drivers. We hypothesize that the dysbiosis …

Understanding the control of Ag restimulation-induced T cell death (RICD), especially in
cancer immunotherapy, where highly proliferating T cells will encounter potentially large …

Background Atopic dermatitis (AD) is a chronic, inflammatory disease characterized by dry,
pruritic skin. In the US, the prevalence of AD has increased over three-fold since the 1970s. …

The multiple zinc finger-containing transcription factor, IKAROS/IKZF1, has multifaceted roles
in hematopoiesis. 1 Numerous studies using both human primary hematopoietic cells and …

Background: Topical glucocorticoids (more commonly termed topical corticosteroids; TCS)
are first-line therapies for management of numerous skin conditions. Topical Steroid …

Background Despite the recent expansion of treatment options in atopic dermatitis (AD),
most management responsibilities fall on the patient and/or caregivers. Disease control often …

… Sun and J. Gay … Ashleigh and A. Nasim … England, JS Butterfield and RJ Ashleigh …

Amplification of the MYCN oncogene predicts treatment resistance in childhood neuroblastoma.
We used a MYC target gene signature that predicts poor neuroblastoma prognosis to …